Metropolitan Life Insurance Company (MetLife)’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,340
| Closed | -$11.2K | – | 23 |
|
|
2024
Q1 | $11.2K | Buy |
4,340
+1,386
| +47% | +$3.58K | ﹤0.01% | 2093 |
|
|
2023
Q4 | $7.39K | Sell |
2,954
-3,255
| -52% | -$8.14K | ﹤0.01% | 2254 |
|
|
2023
Q3 | $12.6K | Hold |
6,209
| – | – | ﹤0.01% | 2112 |
|
|
2023
Q2 | $14.3K | Hold |
6,209
| – | – | ﹤0.01% | 2108 |
|
|
2023
Q1 | $18.8K | Sell |
6,209
-384
| -6% | -$1.16K | ﹤0.01% | 1915 |
|
|
2022
Q4 | $15.4K | Hold |
6,593
| – | – | ﹤0.01% | 2123 |
|
|
2022
Q3 | $12.6K | Buy |
6,593
+4,768
| +261% | +$9.11K | ﹤0.01% | 2228 |
|
|
2022
Q2 | $4.95K | Sell |
1,825
-3,784
| -67% | -$10.3K | ﹤0.01% | 2339 |
|
|
2022
Q1 | $16.7K | Sell |
5,609
-13,522
| -71% | -$40.3K | ﹤0.01% | 2171 |
|
|
2021
Q4 | $74.4K | Sell |
19,131
-3,597
| -16% | -$14K | ﹤0.01% | 2616 |
|
|
2021
Q3 | $97.5K | Buy |
+22,728
| New | +$97.5K | ﹤0.01% | 2534 |
|
|
2018
Q4 | – | Sell |
-12,790
| Closed | -$121K | – | 2547 |
|
|
2018
Q3 | $121K | Buy |
+12,790
| New | +$121K | ﹤0.01% | 2343 |
|